RESUMEN
BACKGROUND: Coronary microvascular dysfunction (CMD) is frequently observed in atrial fibrillation (AF), the most commonly sustained arrhythmia. Nevertheless, an in-depth prognostic significance of CMD in AF is lacking. We aimed to provide insight into the predictive impact of CMD assessed by a novel non-invasive coronary angiography-derived index of microcirculatory resistance (caIMR) for major adverse events (MACE) in AF patients. METHOD: This study included patients with AF who underwent invasive coronary angiography due to suspected cardiac ischemia and did not exhibit obstructive epicardial coronary artery disease (≤50 % stenosis). The caIMR was prospectively evaluated, and the optimal cutoff value for predicting MACE was determined through ROC analysis. RESULT: A total of 463 patients with AF were enrolled. During a median of 33 months of follow-up, 111 (23.97 %) patients had MACE endpoints. The best caIMR cutoff value was 39.28. In patients with MACE, both the mean caIMR and the prevalence of elevated caIMR (caIMR>39.28) were significantly higher compared to those without MACE. An elevated caIMR was linked to a higher risk of MACE (log-rank P < 0.001) and emerged as an independent predictor of clinical outcomes (HR: 4.029; 95 % CI: 2.529-6.418; P < 0.001). In addition, the risk of MACE was higher in high caIMR patients with non-paroxysmal AF (log-rank P < 0.001) and no catheter ablation (log-rank P < 0.001). CONCLUSION: Elevated caIMR is common and showed a vital independent prognostic significance in AF patients. In addition to well-known risk factors, assessment of microvascular function can be a feasible approach for early prevention and a therapeutic target in AF patients.
Asunto(s)
Fibrilación Atrial , Angiografía Coronaria , Circulación Coronaria , Vasos Coronarios , Microcirculación , Valor Predictivo de las Pruebas , Humanos , Fibrilación Atrial/fisiopatología , Fibrilación Atrial/diagnóstico , Fibrilación Atrial/mortalidad , Masculino , Femenino , Persona de Mediana Edad , Anciano , Factores de Riesgo , Vasos Coronarios/fisiopatología , Vasos Coronarios/diagnóstico por imagen , Pronóstico , Medición de Riesgo , Factores de Tiempo , Estudios Prospectivos , Resistencia Vascular , Enfermedad de la Arteria Coronaria/fisiopatología , Enfermedad de la Arteria Coronaria/mortalidad , Enfermedad de la Arteria Coronaria/diagnóstico , Enfermedad de la Arteria Coronaria/diagnóstico por imagen , Enfermedad de la Arteria Coronaria/complicacionesRESUMEN
BACKGROUND: Cardiac remodelling could be a key mechanism in aldosteronemediated cardiovascular morbidity and mortality. Experimental and clinical evidence has demonstrated that aldosterone causes cardiac structural remodelling and dysfunction by its profibrotic and pro-hypertrophic effects, which result mainly from the direct effects on myocardial collagen deposition, inflammation, and oxidative stress. Clinical studies have investigated the aldosterone effects on the heart in different clinical conditions, including general population, essential hypertension, primary aldosteronism, heart failure, and atrial fibrillation. Robust findings indicate that aldosterone or the activation of the cardiac mineralocorticoid receptor can cause damage to myocardial tissue by mechanisms independent of the blood pressure, leading to tissue hypertrophy, fibrosis, and dysfunction. CONCLUSION: Aldosterone-mediated cardiovascular morbidity and mortality mainly result from cardiac structural and functional alterations. In different clinical settings, aldosterone can induce cardiac structural remodelling and dysfunction via several pathological mechanisms, including cardiac fibrosis, inflammation, and oxidative stress. Aldosterone antagonists could effectively decrease or reverse the detrimental aldosterone-mediated changes in the heart.
Asunto(s)
Aldosterona , Estrés Oxidativo , Humanos , Aldosterona/metabolismo , Aldosterona/fisiología , Estrés Oxidativo/fisiología , Remodelación Ventricular/fisiología , Antagonistas de Receptores de Mineralocorticoides/uso terapéutico , Antagonistas de Receptores de Mineralocorticoides/farmacología , Miocardio/metabolismo , Miocardio/patología , Fibrosis , Hiperaldosteronismo/fisiopatología , Receptores de Mineralocorticoides/fisiología , Receptores de Mineralocorticoides/metabolismo , Insuficiencia Cardíaca/fisiopatologíaRESUMEN
Aldosterone has hypertrophic and profibrotic effects on the heart. This study aims to determine the relationship between serum aldosterone concentration (SAC) and aldosterone-to-renin ratio (ARR) with left ventricular (LV) geometry and diastolic function in essential hypertension (EH). We investigated 213 EH patients (50.3 ± 12.6 years; 57.7% male). SAC, ARR measurements, and echocardiographic analysis were performed for participants. Overall, stepwise multiple regression analysis showed significant associations between SAC and interventricular septum, LV posterior wall thickness, LV amass, LV mass index, e' velocity, a' velocity, and E/e' ratio after adjustment of potentially confounding covariates. When patients were divided into three SAC tertiles, multivariate-adjusted analysis of covariance (ANCOVA) demonstrated a significant increase in LV mass (P Ë 0.001), LV mass index (P Ë 0.001), relative wall thickness (P = 0.003), interventricular septum (P = 0.001), LV posterior wall thickness (P = 0.001) and E/e' ratio (P Ë 0.001), but a decrease in e' velocity (P = 0.002) from the first to third tertile of SAC. In logistic regression analysis, increased SAC was independently associated with concentric LV hypertrophy [OR: 1.21, 95% CI: 1.11-1.33, P Ë 0.001]. No significant associations were found between ARR and echocardiographic parameters of LV structure or diastolic function. In conclusion, SAC, but not ARR, is independently associated with echocardiographic indices of LV structure and diastolic function and is also related to concentric LV hypertrophy. Our findings suggest that aldosterone's pro-hypertrophic and myocardial fibrosis effects contribute to alterations in LV structure and diastolic function in EH beyond blood pressure.
Asunto(s)
Hipertensión , Disfunción Ventricular Izquierda , Humanos , Masculino , Femenino , Aldosterona , Hipertensión Esencial/complicaciones , Ecocardiografía , Hipertrofia Ventricular Izquierda , Función Ventricular Izquierda , DiástoleRESUMEN
Visit-to-visit variability (VVV) of blood pressure (BP) can facilitate in predicting future reduced ejection fractions cases. In the recent past, the prognostic significance of visitto-visit variability of BP has been examined widely in patients with a high risk of cardiovascular disease. The findings of numerous investigations have indicated that increased visit-to-visit variability of blood pressure can lead to better estimation or proper treatments that can minimize blood pressure variability and associated risks while enhancing clinical outcomes. However, inconsistent data of the visit-to-visit hypothesis in the post-hoc analysis have also been explored. Therefore, this review discusses recent analysis, background, and reports of the limitations of visit-to-visit blood pressure variability (VVV-BP) and the prognostic significance of visit-to-visit blood pressure variability in populations at high risk of reduced ejection fractions in predictions of future vascular diseases. The role of the antihypertensive drugs is highlighted while describing the clinical implications and future research directions.